GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Change in Accured Expenses came in at $19.0 million in Q2 2026, up 371.43% on a YoY basis from $4.0 million in Q2 2025, and up 107.6% quarter-over-quarter from -$250.0 million in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Change in Accured Expenses for 4 consecutive years, with $19.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses rose 371.43% year-over-year to $19.0 million; the trailing twelve-month figure through Jun 2026 stood at $70.0 million (down 28.57% YoY), and the FY2025 full-year result was $94.0 million, up 141.03% from the prior year.
- Change in Accured Expenses advanced to $19.0 million in Q2 2026 per GEHC's latest filing, from -$250.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $178.0 million in Q3 2025 and bottomed at -$250.0 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged $14.1 million across 4 years, with a median of $67.5 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses sank 488.24% in 2025, then soared 371.43% in 2026.
- Over 4 years, Change in Accured Expenses stood at $116.0 million in 2023, then rose by 17.24% to $136.0 million in 2024, then decreased by 9.56% to $123.0 million in 2025, then plunged by 84.55% to $19.0 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $19.0 million, -$250.0 million, and $123.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 19.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | -1.99 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -700,000.00 |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 5.23 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -148,000.00 |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 9.50 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | -17.90 Mn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 10.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.00 Mn |
| Mar 31, 2026 | -250.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Sep 30, 2025 | 178.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -200.00 Mn |
| Dec 31, 2024 | 136.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Jun 30, 2024 | -232.00 Mn |
| Mar 31, 2024 | -34.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Sep 30, 2023 | 151.00 Mn |